Plasma microRNA-100 is associated with coronary plaque vulnerability

Circulation Journal

Volumn 79, Issue 2, 2015, Pages 413-418

  Soeki, Takeshi ^a   Yamaguchi, Koji ^a   Niki, Toshiyuki ^b,c   Uematsu, Etsuko ^a   Bando, Sachiko ^a   Matsuura, Tomomi ^a   Ise, Takayuki ^a   Kusunose, Kenya ^a   Hotchi, Junko ^a   Tobiume, Takeshi ^a   Yagi, Shusuke ^a   Fukuda, Daiju ^a   Taketani, Yoshio ^b,c   Iwase, Takashi ^a   Yamada, Hirotsugu ^a   Wakatsuki, Tetsuzo ^a   Shimabukuro, Michio ^a   Sata, Masataka ^a  

^a Department of Cardiovascular Medicine ^*  (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c SHIKOKU MEDICAL CENTER FOR CHILDREN AND ADULTS   (Japan)

Author keywords

Coronary artery disease; Coronary circulation; Intravascular ultrasound; microRNA

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA 100; MICRORNA 126; MICRORNA 127; MICRORNA 133A; MICRORNA 145; MICRORNA 155; MICRORNA 208A; MICRORNA 223; MICRORNA 499; MICRORNA 92A; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; MICRORNA; MIRN100 MICRORNA, HUMAN;

AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CORONARY PLAQUE VULNERABILITY; CORONARY SINUS; FEMALE; HEART FUNCTION; HUMAN; INTRAVASCULAR ULTRASOUND; LIPID ANALYSIS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CHARACTERIZATION; ATHEROSCLEROTIC PLAQUE; BLOOD; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC;

EID: 84928251309     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0958     Document Type: Article

References (33)

1. van Rooij E, Olson EN. MicroRNAs: Powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 2007; 117: 2369–2376.
2. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA2008; 105: 10513–10518.
3. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10: 1470–1476.
4. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: Novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 2012; 110: 483–495.
5. Libby P. Vascular biology of atherosclerosis: Overview and state of the art. Am J Cardiol 2003; 91: 3A–6A.
6. Kawasaki M, Takatsu H, Noda T, Sano K, Ito Y, Hayakawa K, et al. In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 2002; 105: 2487–2492.
7. Amano T, Matsubara T, Uetani T, Nanki M, Marui N, Kato M, et al. Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions integrated backscatter intravascular ultrasound study. J Am Coll Cardiol2007; 49: 1149–1156.
8. Ohota M, Kawasaki M, Ismail TF, Hattori K, Serruys PW, Ozaki Y. A histological and clinical comparison of new and conventional integrated backscatter intravascular ultrasound (IB-IVUS). Circ J 2012; 76: 1678–1686.
9. Nakayama N, Hibi K, Endo M, Miyazawa A, Suzuki H, Maejima N, et al. Validity and reliability of new intravascular ultrasound analysis software for morphological measurement of coronary artery disease. Circ J 2013; 77: 424–431.
10. Sano K, Kawasaki M, Ishihara Y, Okubo M, Tsuchiya K, Nishigaki K, et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2006; 47: 734–741.
11. Amano T, Matsubara T, Uetani T, Kato M, Kato B, Yoshida T, et al. Lipid-rich plaques predict non-target-lesion ischemic events in patients undergoing percutaneous coronary intervention. Circ J 2011; 75: 157–166.
12. Yamaguchi K, Wakatsuki T, Soeki T, Niki T, Taketani Y, Oeduka H, et al. Effects of telmisartan on inflammatory cytokines and coronary plaque component as assessed on integrated backscatter intravascular ultrasound in hypertensive patients. Circ J 2013; 78: 240–247.
13. Li J, Yao B, Huang H, Wang Z, Sun C, Fan Y, et al. Real-time polymerase chain reaction microRNA detection based on enzymatic stem-loop probes ligation. Anal Chem 2009; 81: 5446–5451.
14. Zile MR, Mehurg SM, Arroyo JE, Stroud RE, DeSantis SM, Spinale FG. Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction. Circ Cardiovasc Genet 2011; 4: 614–619.
15. De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S, Zeiher AM. Transcoronary concentration gradients of circulating microRNAs. Circulation2011; 124: 1936–1944.
16. Santovito D, Mezzetti A, Cipollone F. MicroRNAs and atherosclerosis: New actors for an old movie. Nutr Metab Cardiovasc Dis2012; 22: 937–943.
17. Chen LJ, Lim SH, Yeh YT, Lien SC, Chiu JJ. Roles of microRNAs in atherosclerosis and restenosis. J Biomed Sci 2012; 19: 79.
18. Tsitsiou E, Lindsay MA. microRNAs and the immune response. Curr Opin Pharmacol2009; 9: 514–520.
19. Zernecke A. MicroRNAs in the regulation of immune cell functions: Implications for atherosclerotic vascular disease. Thromb Haemost 2012; 107: 626–633.
20. Cipollone F, Felicioni L, Sarzani R, Ucchino S, Spigonardo F, Mandolini C, et al. A unique microRNA signature associated with plaque instability in humans. Stroke 2011; 42: 2556–2563.
21. Grundmann S, Hans FP, Kinniry S, Heinke J, Helbing T, Bluhm F, et al. MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells. Circulation 2011; 123: 999–1009.
22. Wang X, Li L, Li M, Dang X, Wan L, Wang N, et al. Knockdown of mTOR by lentivirus-mediated RNA interference suppresses atherosclerosis and stabilizes plaques via a decrease of macrophages by autophagy in apolipoprotein E-defcient mice. Int J Mol Med 2013; 32: 1215–1221.
23. Ma KL, Liu J, Wang CX, Ni J, Zhang Y, Wu Y, et al. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation. Cardiovasc Res 2013; 100: 450–460.
24. Sternberg Z, Ghanim H, Gillotti KM, Tario JD Jr, Munschauer F, Curl R, et al. Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood. Atherosclerosis 2013; 229: 338–347.
25. Shi W, Alajez NM, Bastianutto C, Hui AB, Mocanu JD, Ito E, et al. Signifcance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. Int J Cancer 2010; 126: 2036–2048.
26. Inoue K, Sugiyama A, Reid PC, Ito Y, Miyauchi K, Mukai S, et al. Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol 2007; 27: 161–167.
27. Soeki T, Niki T, Kusunose K, Bando S, Hirata Y, Tomita N, et al. Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability. J Cardiol 2011; 58: 151–157.
28. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA2008; 105: 1516–1521.
29. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009; 2: ra81.
30. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010; 107: 677–684.
31. D’Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J2010; 31: 2765–2773.
32. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, et al. Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010; 31: 659–666.
33. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, et al. Circulating MicroRNA-208b and MicroRNA-499 refect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet2010; 3: 499–506.